Royal Capital Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.79M | Buy |
9,635
+13
| +0.1% | +$2.41K | 1.19% | 22 |
|
|
2025
Q1 | $2.02M | Buy |
9,622
+12
| +0.1% | +$2.51K | 1.41% | 21 |
|
|
2024
Q4 | $1.71M | Sell |
9,610
-407
| -4% | -$72.3K | 1.2% | 21 |
|
|
2024
Q3 | $1.98M | Sell |
10,017
-153
| -2% | -$30.2K | 1.4% | 19 |
|
|
2024
Q2 | $1.74M | Sell |
10,170
-84
| -0.8% | -$14.4K | 1.31% | 20 |
|
|
2024
Q1 | $1.87M | Sell |
10,254
-65
| -0.6% | -$11.8K | 1.47% | 19 |
|
|
2023
Q4 | $1.6M | Sell |
10,319
-62
| -0.6% | -$9.61K | 1.38% | 19 |
|
|
2023
Q3 | $1.55M | Sell |
10,381
-138
| -1% | -$20.6K | 1.48% | 20 |
|
|
2023
Q2 | $1.42M | Sell |
10,519
-137
| -1% | -$18.5K | 1.34% | 22 |
|
|
2023
Q1 | $1.7M | Sell |
10,656
-76
| -0.7% | -$12.1K | 1.71% | 16 |
|
|
2022
Q4 | $1.73M | Buy |
10,732
+7
| +0.1% | +$1.13K | 1.84% | 15 |
|
|
2022
Q3 | $1.44M | Buy |
10,725
+179
| +2% | +$24K | 1.68% | 20 |
|
|
2022
Q2 | $1.62M | Buy |
10,546
+11
| +0.1% | +$1.69K | 1.75% | 18 |
|
|
2022
Q1 | $1.71M | Buy |
10,535
+300
| +3% | +$48.6K | 1.67% | 19 |
|
|
2021
Q4 | $1.39M | Buy |
+10,235
| New | +$1.39M | 1.34% | 21 |
|